Skip to main content
. 2013 Oct 8;35(3):1907–1915. doi: 10.1007/s13277-013-1256-3

Table 1.

Characteristics of case–control studies included in XPD Asp312Asn (G312A) polymorphism and breast cancer risk

First author Year Country Ethnicity Genotyping methods Source of Control Cases Controls
GG GA AA GG GA AA
Hussien 2012 Egypt Caucasian ARMS-PCR HB 12 45 43 25 50 25
Jelonek 2010 Poland Caucasian PCR-RFLP PB 41 59 21 85 123 23
Wang 2010 China Asian PCR-RFLP PB 624 388 220 925 315 193
Crew 2007 USA Mix Taqman PB 415 478 138 490 454 139
Shen 2006 USA Mix Taqman PB 60 80 16 59 64 30
Jorgensen 2007 USA Mix Taqman PB 110 128 22 102 142 29
Debniak 2006 Poland Caucasian PCR-RFLP PB 672 785 269 492 597 173
Mechanic(a) 2006 USA Caucasian PCR-RFLP PB 543 589 130 489 516 128
Mechanic(b) 2006 USA African-American PCR-RFLP PB 564 181 15 517 145 13
Brauch 2004 Germany Caucasian PCR-RFLP PB 347 173 47 276 255 79
Shi 2004 USA Caucasian PCR-RFLP PB 29 32 8 46 27 6
Tang 2002 USA Mix PCR-RFLP PB 52 31 7 74 28 10

PCR-RFLP PCR-restriction fragment length polymorphism, HB hospital based, PB population based